e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Manifestations, scores and prognosis of community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The results of immunotherapy of community acquired pneumonia
U. Farkhutdinov, A. Mirchaidarov, R. Farkhutdinov (Ufa, Russian Federation)
Source:
Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Session:
Manifestations, scores and prognosis of community-acquired pneumonia
Session type:
Thematic Poster Session
Number:
2770
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Farkhutdinov, A. Mirchaidarov, R. Farkhutdinov (Ufa, Russian Federation). The results of immunotherapy of community acquired pneumonia. Eur Respir J 2013; 42: Suppl. 57, 2770
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Definition and history of sarcoidosis
Related content which might interest you:
Importance of immunostimulation for community acquired pneumonia management
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Community acquired pneumonia in patients with ambulatory treatment. Etiology and evolution
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Fatal outcomes in patients with community acquired pneumonia
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Community acquired lung respiratory infections in HIV-infected patients: Microbial etiology and outcome
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
The impact of mixed etiology in community acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Severity scores and management of community acquired pneumonia
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Asthma diagnosis in children with community-acquired pneumonia: New challenges
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Modification of empirical antibiotic therapy in community acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Inflammatory markers and community acquired pneumonia (CAP): Prognosis analisis and predictive capacity in the short term
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Community acquired pneumonia in asthma patients
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Development of an antibody therapy for the treatment of pneumonia
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Features of pneumonia diagnostics in burn trauma patients
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Markers of cellular immunity in the diagnosis of tuberculosis pleurisy
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Clustering of multiplex-qPCR data for the detection of respiratory viruses in acute bronchiolitis
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Cytokine and chemokine profile in a cohort of children with community acquired pneumonia
Source: International Congress 2016 – Paediatric respiratory infection
Year: 2016
Association of breastfeeding and respiratory infections in infants
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014
Serum YKL-40 is elevated in children with pneumonia and RSV infection
Source: International Congress 2014 – Virus-triggered lower respiratory disease in children
Year: 2014
Clinical peculiarities of mycoplasma infection in children with community pneumonia
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016
Microbial aetiology of community-acquired pneumonia and it's relation with ICS use in patients with COPD – Results from the German competence network CAPNETZ
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Risk factors for pleural complications in children with community acquired pneumonia
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept